Stimulation of B lymphocytes through their antigen receptor (BCR) results in rapid increases in tyrosine phosphorylation of a number of proteins, which leads to a cascade of biochemical changes that initiates B cell proliferation and dierentiation or growth inhibition. A novel cDNA, designed APS, encoding an adaptor protein with a Pleckstrin homology (PH) domain, Src homology 2 (SH2) domain, and a tyrosine phosphorylation site was cloned from a B cell cDNA library using a yeast two hybrid system. APS is structurally similar to SH2-B, an SH2 protein that potentially binds to the immunoreceptor tyrosine-based activation motif (ITAM) as well as Lnk which is postulated to be a signal transducer that links T-cell receptor to phospholipase Cg, Grb2 and phosphatidylinositol 3-kinase. APS expressed only in human Burkitt's lymphoma cells among cell lines we examined and tyrosine phosphorylated in response to BCR stimulation. APS bound to Shc irrespective of stimulation and bound to Grb2 after stimulation, suggesting that it plays a role in linkage from BCR to Shc/Grb2 pathway. These results indicate that APS, SH2-B and Lnk form a new adaptor family that links immune receptors to signaling pathways involved in tyrosine-phosphorylation.
Introduction
Engagement of the B cell antigen receptor (BCR) or T cell antigen receptor (TCR) leads to a cascade of biochemical events that culminates in lymphocyte activation (Cambier and Ranson, 1987) . The T and B cell antigen receptors signal through associated CD3/ TCRz/Z and the Iga/b (mb1/B29) chains respectively. These receptor associated polypeptides contain within their cytoplasmic domains a phylogenically conserved motif, the immunoreceptor tyrosine-based activation motif (ITAM) bearing two tyrosine residues separated by 10 or 11 residues (Reth, 1989; Cambier, 1995a) . This motif is also present in various forms of Fc receptors (Cambier, 1995b) . Clustering of chimeric receptors bearing the ITAMs initiates activation cascades, suggesting that this short sequence carries sucient structural information to activate signaling pathways (Irving and Weiss, 1991; Irving et al., 1993; Letourneur and Klausner, 1991) . The immediate biochemical event following TCR and BCR stimulation is tyrosine phosphorylation of the ITAMs and a number of cellular substrates. Since none of the BCR or TCR subunits possesses intrinsic protein tyrosine kinase (PTK) activity, receptor associated cytoplasmic PTKs are thought to play an important role in this early event. Indeed, CD3/z chains of the TCR and CD4/8 co-receptors associate with the Src-family kinases Fyn and Lck, respectively (Veillette et al., 1988; Samelson et al., 1990; Timson et al., 1992) . Iga chain may physically associate with Lyn or Fyn (Clark et al., 1992) . After tyrosine-phosphorylation by these Src-family PTKs, the ITAMs recruit the Syk and ZAP70 PTKs to BCR and TCR complexes respectively (Wange et al., 1993; Iwashima et al., 1994; Kimura et al., 1996) . Activated PTKs phosphorylate numerous cellular proteins, including phospholipase C (PLC)g1, Vav proto-oncogene product and adaptor proteins such as Shc and Crk (Carter et al., 1991; Bustelo and Barbacid, 1992; Panchamoorthy et al., 1996; Tezuka et al., 1996) . Recently, c-Cbl has shown to be a major substrate of PTKs upon BCR stimulation and interacts with Fyn and Syk kinases as well as Grb2, Shc, Crk and phosphatidylinositol-3-OH kinase (PI3K) p85 subunit (Panchamoorthy et al., 1996; Tezuka et al., 1996) . SLP-76 (SH2 domain-containing leukocyte protein of 76 kDa) has shown to be a substrate of ZAP70 and to be associated with Grb2 and PLCg1 (Wardenburg et al., 1996) . Lnk is a 38 kDa tyrosine-phosphorylated protein which also binds to PLCg1, PI3K and Grb2 in response to T cell activation (Huang et al., 1995) . HS1 has shown to be tyrosine phosphorylated in response to BCR stimulation and to play a role in apoptosis (Yamanashi et al., 1993; Fukuda et al., 1995) . All these signal transduction proteins contain Src homology 2 (SH2) or SH3 domains which lead to protein ± protein interactions. Identi®cation and characterization of the PTK substrates has become a major focus of studies aimed at elucidating the mechanism of lymphocyte signaling.
The SH2 domain interacts with the phosphotyrosine-containing peptide sequences and this domain is present in many signal transducing molecules. Several methods have been utilized to clone SH2 proteins. For example, a number of SH2 proteins were isolated by screening bacterial expression libraries with the tyrosine phosphorylated C-terminus of the EGFreceptor; termed the CORT (cloning of receptor targets) method (Skolnik et al., 1991) . Recently, a yeast two-hybrid system has been successfully used for screening. Grb-IR was cloned by using the tyrosine kinase domain of the insulin receptor as bait (Liu and Roth, 1995) . A yeast tribrid system has been developed to isolate cDNAs encoding proteins that interact with the tyrosine-phosphorylated FceRIg ITAM, and novel SH2 containing proteins, SH2-B and SHIP (SH2-domain containing inositol polyphosphate 5-phosphatase) were cloned by this method (Osborne et al., 1995 (Osborne et al., , 1996 . We used oncogenic c-kit kinase domain as bait, expecting high kinase activity of the bait. As expected, several known and novel SH2 proteins were cloned from some two-hybrid cDNA libraries. One of them is a novel SH2 protein (APS) which is structurally similar to SH2-B and Lnk. APS was exclusively expressed in B cells among cell lines we examined and tyrosine phosphorylated in response to BCR stimulation. We propose that APS, SH2-B and Lnk form a new adaptor family which strongly associates with immunoreceptor signaling.
Results

Cloning of a c-kit substrate by yeast two-hybrid system
To ®nd an unidenti®ed signal transduction pathway from c-kit tyrosine kinase, we employed the yeast twohybrid system. The hybrid bait consisted of DNAbinding/dimerization domain of LexA and oncogenic ckit kinase domain (c-kit D816V) (Kitayama et al., 1995) . D816V point mutation causes constitutive activation of the c-kit tyrosine kinase domain without ligand, and hematopoietic cells expressing this mutant receptor form tumors in mice. From several two-hybrid cDNA libraries, we obtained known SH2 proteins including Crk, p85 subunit of PI3K and PLCg as well as a novel SH2 protein named APS on the basis of their structural properties, described later. Although PI3K SH2 domain interacted with D816V mutant c-kit kinase domain as strongly as with the wild type c-kit, APS, PLCg, and Crk SH2 domains bound to mutant c-kit more strongly than to the wild type as judged by lacZ assay (Figure 1) . Thus, use of oncogenic c-kit kinase domain as bait facilitated cloning of novel SH2 proteins.
APS was obtained from a human B-cell cDNA library. The initial APS cDNA clone obtained from the two-hybrid library contained about 0.8 kb of the 3' end of the mRNA. Full length APS cDNA was obtained by rescreening of a human B cell cDNA library and RACE ± PCR (Figure 2a) . Although there was still no in-frame stop codon in the upstream region, immunoblotting demonstrated that the size of the polypeptide encoded by the endogenous APS gene in human B cell lines (see Figure 5 ) was identical to that encoded by our cloned gene (data not shown). Thus, the ®rst ATG codon in the RACE ± PCR product is most likely the real start codon.
Many SH2 proteins such as Shc and PLCg1 are tyrosine phosphorylated after binding to receptor tyrosine kinases. Since APS was cloned as a binding protein to c-kit tyrosine kinase domain, it was expected to be a substrate of c-kit. Thus, SCF-dependent tyrosine phosphorylation of APS was assessed using 293T reconstitution system (Figure 3 ). Myc epitope tagged APS (Myc-APS) was expressed in 293T cells with c-kit, then the cells were stimulated with SCF. APS as well as c-kit was tyrosine-phosphorylated in response to SCF, and c-kit was co-immunoprecipitated with APS ( Figure 3a) . These results indicate that APS bound to c-kit not only in yeast but also in cells and that APS was tyrosine-phosphorylated by c-kit tyrosine kinase. APS was also tyrosine phosphorylated in response to SCF in the MC9 mast cell transformant ectopically expressing APS (data not shown). Anti-Myc Immunoblot revealed the presence of a signi®cant amount of degradation product of APS (Figure 3b ) in 293T cells. However, tyrosine phosphorylation was observed only in the largest intact form of APS ( Figure  3a ). Myc-epitope tag was localized at the N-terminal end, suggesting that the tyrosine phosphorylation occurred at the C-terminal end. In Figure 3c , Myc tagged APS SH2 domain region (Myc-SH2; codon 404 ± 517) or SH2 domain and C-terminal region (Myc-SH2C; codon 404 ± 632) were expressed with c-kit in 293T cells and immunoprecipitated with anti-Myc. Myc-SH2C but not Myc-SH2 was tyrosine phosphorylated in response to SCF. Since the C-terminal region contains only a single tyrosine residue close to the Cterminal end, this tyrosine residue is likely to be the tyrosine phosphorylation site.
APS is structurally related to SH2-B and Lnk
A homology search of the deduced amino acid sequences in GenBank revealed a span of about 100 amino acids with Pleckstrin homology (PH) in the middle and an SH2 domain of about 100 amino acids near the C-terminal region. Since there was no enzymatic motif in the sequence, this gene product was expected to be an adaptor molecule like Grb2 and Shc. Thus, we termed this gene APS (adaptor molecule containing PH and SH2 domains) ( Figure 2b ). APS was found to be very similar but not identical to an uncharacterized SH2 protein, SH2-B which was cloned previously from a rat mast cell line. SH2-B was identi®ed in a yeast tribrid screening for proteins that interact with the tyrosine phosphorylated FceRI (highanity IgE receptor) g chain cytosolic tail and shown to bind to tyrosine phosphorylated ITAM sequences (Osborne, 1995) . The SH2 domain sequence of human SH2-B was predicted from sequences of human expressed sequence tags (ESTs) in the database (Figure 2c) . A schematic comparison of APS and and SH2 domains showed little similarity. The PH domains of APS and SH2-B are 58% identical and are most similar (23% identical) to that of IRS1 (insulin receptor substrate-1) among PH domain-containing proteins. The SH2 domains of APS and SH2-B are almost identical (80% identity). The SH2 domain of human SH2-B is 96% identical to the rat counterpart. About 100 C-terminal amino acids dier between APS and SH2-B (14% identity), although 10 C-terminal end The SH2 domains of APS and SH2-B are also very similar to that of Lnk (72% identity). Lnk is a 38 kDa protein which is tyrosine phosphorylated in response to TCR stimulation (Huang et al., 1995) . The predicted tyrosine phosphorylation site of Lnk is close to the Cterminal end sequence, DNQYTPL, which is very similar to the C-terminal end of APS and SH2-B. This is consistent with our notion that the C-terminal end tyrosine residue is the tyrosine-phosphorylation site of APS (Figure 3) . Interestingly, 40 N-terminal amino acids of Lnk showed signi®cant similarity (about 40% identity) to the C-terminal half of PH domains of APS and SH2-B. Moreover, upstream 20 amino acid sequences from the predicted ®rst methionine also showed close similarity (about 60% identity) to the PH domains of APS and SH2-B. Thus, there may be an upstream ATG initiation codon and the gene for Lnk may encode a longer protein species like APS and SH2-B. Since SH2-B and Lnk have shown to be associated with an immunoreceptor signaling system, APS is also expected to be linked to an immunoreceptor system.
Expression of APS in tissues and cells
We examined APS expression in various tissues and cell lines (Figure 4) . A 2.3 kb message of APS was detected in various tissues including spleen, prostate, testis, uterus, small intestine and skeletal muscle. In peripheral leukocyte, a smaller size mRNA was detected, although we have not determined the structure of this message. Among the hematopoietic cell lines we examined, APS was exclusively expressed in Burkitt's lymphoma-derived B cell lines, Daudi and Raji. A T-cell line (Jurkat) did not express APS. No expression was seen in cell lines from solid tumors. These results suggest that APS functions in B cells.
Tyrosine phosphorylation of APS and its associated proteins in B cells
Structural similarity to Lnk and APS and expression in B cells suggest that APS is a down stream molecule of BCR. We generated antiserum against APS C-terminal region and used it for detection of tyrosine phosphorylation of APS and its associated proteins. To investigate the involvement of APS in BCR signaling, we utilized surface IgM-expressing human B-lymphoblastoid cell line, Raji. The BCR on Raji cells was cross-linked with anti-IgM antibody for various time points, and anti-APS immunoprecipitates were subjected to SDS ± PAGE, followed by anti-phosphotyrosine (PY) immunoblotting. Anti-IgM stimulation led to a time-dependent increase in tyrosine phosphorylation of a number of polypeptides (Figure 5a ). Anti-APS antiserum precipitated 85 kDa APS protein and BCR stimulation resulted in a slight mobility shift probably due to phosphorylation (Figure 5d , arrows). Immunoblotting with anti-PY revealed that APS was tyrosine phosphorylated in response to BCR stimulation (Figure 5b and c) . Tyrosine phosphorylation of Figure 5 ). Preimmune serum did not precipitate these polypeptides (data not shown). Association of APS with p145 was detected even at 1 min stimulation (Figure 5c ), To identify these associated molecules, cell extracts after stimulation for 10 min were immunoprecipitated with anti-APS, anti-Cbl, anti-Shc, anti-Grb2, or anti-PI3K p85 subunit, then blotted with anti-PY ( Figure  6 ). We could not detect tyrosine phosphorylation of p85 subunit which is consistent with a previous report (Panchamoorthy et al., 1996) . The APS-associated phosphoproteins were quite similar to those associated with Grb2 and c-Cbl. The major APS binding phosphoprotein, p145 was precipitated with all other antibodies, and it is probably SHIP which is reported to be associated with Shc and Grb2 (Damen et al., 1996; Osborne et al., 1996) . A marginal amount of p120 c-Cbl was precipitated with APS. p75 and p65 were also associated with Grb2 and c-Cbl, although the identity was not clear. Shc was detected in anti-Grb2 immunoprecipitates but Grb2 was not in anti-Shc immunoprecipitates, suggesting that only a small fraction of Shc was associated with Grb2 in our condition. Cell lysates were also precipitated with antisyk and anti-fyn, however there was no close association of APS with these two tyrosine-kinases (data not shown). Grb2 was associated with APS after stimulation, while Shc associated with APS irrespective of stimulation. It is notable, however, that tyrosine phosphorylated p52 Shc band was not detected in anti-APS Immunoprecipitates. This indicates that Shc associated with APS did not receive tyrosine phosphorylation by BCR stimulation (compare IP with anti-APS and anti-Shc). Anti-Shc reacted with two protein species, p52 and p45 in Raji cells but only p52 was tyrosine-phosphorylated by BCR stimulation. APS bound to both forms. We could not detect APS in the immunoprecipitates with anti-Grb2 and anti-Shc, probably because of low level of expression and phosphorylation of APS (see Figure 5a ) compared with Shc and Grb2.
To con®rm the binding of SH2 proteins with APS, GST-fusion proteins were utilized for an in vitro binding study. Raji cell extracts were incubated with GST-SH2, GST-PH, or phosphorylated or unphosphorylated GST-C terminal region (GST-C; codon 551 ± 632). GST-C was tyrosine phosphorylated by being produced in TKB1 strain (Weiner et al., 1994) . As shown in Figure 7a , tyrosine phosphorylated p85 and p40 were speci®cally bound to GST-SH2. p85 could be APS itself. To examine this possibility, GST-SH2 was incubated with Myc-APS produced in MC9 transformants, then binding was detected with antiMyc antibody. A part of Myc-APS was tyrosine phosphorylated in MC9 cells under normal growth Cloning of a novel BCR linked adaptor M Yokouchi et al condition, and SCF treatment markedly increased in APS tyrosine phosphorylation level (data not shown). Tyrosine phosphorylated Myc-APS was bound to GST-SH2 but not to GST alone (Figure 7b ), suggesting that p85 associated with GST-SH2 in the Raji cell extract was APS itself. p40 was not identi®ed. Cbl and Grb2 bound to the tyrosine phosphorylated Cterminal region of APS but not to the unphosphorylated counterpart (Figure 7c ). This binding did not depend on BCR stimulation. Since Cbl does not contain SH2 domain, binding of Cbl to the tyrosine phosphorylated APS C-terminal region may be indirect. Neither GST-SH2, GST-PH nor tyrosine phosphorylated GST-C bound to Shc, suggesting that APS bound to Shc through its N-terminal region.
Discussion
In this study we cloned a novel c-kit binding protein, APS which is structurally related to SH2-B and Lnk. The structure, expression and response to TCR (Lnk) and BCR (APS) of such adaptor molecules indicate that they are likely to be involved in immunoreceptor signaling. APS and SH2-B contain N-terminal proline rich motif, PH domain and SH2 domain, and Lnk contains part of the PH domain and SH2 domain. Since the SH2 domains of these adaptor-like molecules are almost identical, they are likely to recognize very similar sequences containing phosphotyrosine. SH2-B has shown to bind to the ITAM sequence of FceRIg (Osborne et al., 1995) and Lnk was suggested to bind to one of the CD3 chains (Huang et al., 1995) . APS is also tyrosine phosphorylated in response to BCR stimulation. Thus, it is highly likely that SH2 domains of this family recognize tyrosine phosphorylated ITAM sequences.
Among these three genes, Lnk lacks an N-terminal region and a half of the PH domain. However, Lnk gene may also encode a larger polypeptide because reported Lnk cDNA is about 3 kb, whereas its mRNA size is a 4.3 kb in Northern blot analysis. This is supported by the fact that a 22 amino acid sequence upstream from the reported ®rst Met on Lnk is very similar to the corresponding sequences of APS and SH2-B (Figure 2) . Moreover, in a report by Huang et al. (1995) , anti-Lnk antibody recognized 70 ± 80 kDa protein in lymph node lymphocytes in addition to 38 kDa protein. Thus, the 38 kDa protein may be encoded by mRNA produced by an alternative splicing or dierent transcription initiation of Lnk gene. We also obtained a number of small size cDNAs of APS containing the SH2 domain and C-terminal region but lacking the N-terminal region and PH domain by library screening as well as RACE ± PCR. This could be due to the GC rich structure of APS mRNA because we did not detect smaller size mRNA and protein of APS in Raji cells by Northern-and immunoblotting. However, smaller size APS species containing SH2 domain and C-terminal region may be present in tissues or other cell lines like 38 kDa Lnk.
The predicted tyrosine phosphorylation site of Lnk is near the C-terminal end sequence, RAIDNQYTPL, which is related to the C-terminal regions of APS and SH2-B. We also found that C-terminal end tyrosine residue of APS is the site for phosphorylation by c-kit. As reported by Huang et al. (1995) , DNQYTPL resembles the ®rst half of the ITAM consensus sequence (DXXYXXL). However, the three amino acid sequence next to Y of APS and that of SH2-B are SFY and SFV respectively, which are dierent from that of Lnk (TPL). C-terminal tyrosine phosphorylated peptide of Lnk is reported to bind to Grb2, PI3K p85 subunit, and PLCg1 in vitro. We also found that the tyrosine phosphorylated C-terminal region of APS can bind to Grb2 and Cbl. However, we did not detect binding to PI3 p85 subunit and PLCg1 (data not shown). This may be due to low abundance of these molecules in B cells or due to the low anity of the Y(P)SFY sequence.
The overall structure of APS and SH2-B resembles that of Grb7 and Grb10/Grb-IR family genes (Liu and Roth, 1995; Margolis et al., 1992; Ooi et al., 1995) . Grb7, Grb10, and Grb-IR have a Pro-rich motif, PH domain and SH2 domain, but not a C-terminal tyrosine phosphorylation site. Although they are implicated in signaling of receptor tyrosine kinases including EGF receptor, Ret, and insulin receptor (Stein et al., 1994; Pandey et al., 1995) , their physiological function has not been elucidated. Some structural relationship between APS and Grb7 genes may imply functional similarity between these two families.
The PH domain of the APS family members is most similar to that of IRS1. The PH domain of IRS1 has shown to be important for coupling of the insulin receptor to IRS1 in 32D cells (Yenush et al., 1996) . Although the relevant ligand for the PH domain has not been identi®ed, the PH domain is postulated to bind to phosphorylated membrane components including phosphorylated PI (Pawson, 1995) , Thus, the PH Figure 6 In vivo association of APS with Grb2 and Shc.
Immunoprecipitates from cell lysates of 1610 8 unstimulated (7) or anti-IgM-simulated (+) Raji cells were carried out with the indicated antibodies. Immunoprecipitates or total cell lysates (TCL) were resolved on 9% SDS ± PAGE and subjected to immunoblotting with antibodies indicated on the right domain may be involved in membrane anchorage of APS and in ecient coupling of this molecule to the immunoreceptor complex.
Our results (Figure 7 ) suggest that SH2 domain of APS binds to its own tyrosine phosphorylated Cterminal region. This implies that tyrosine phosphorylation of the C-terminal region may be a trigger of intermolecular binding of the SH2 domain with the Cterminus or homodimerization of APS. This could lead to the release of APS from tyrosine-kinase complex and also induce translocation of APS to downstream target sites as in the case of Crk (Rosen et al., 1996) . The Cterminal tyrosine phosphorylation site of APS also serves as a docking site for Grb2 in Raji cells. Since most of the tyrosine phosphorylated proteins that were co-immunoprecipitated with APS except for p85 APS itself were quite similar to those co-immunoprecipitated with Grb2, these associated proteins may bind to APS through Grb2. Grb2 has shown to associate with SOS, an GTP exchanger for Ras, thereby activating Ras signaling pathway. Thus, APS can be potentially involved in coupling from immunoreceptor to Ras signaling. APS also constitutively associated with Shc probably through the N-terminal region. However, associated Shc did not receive tyrsoine phosphorylation, raising the possibility that APS rather suppresses Shc function by binding. Since the N-terminal region contains proline rich motif which is a potential SH3 binding site, this region may also associate with unidenti®ed proteins which is important for APS function.
APS as well as SH-2B were expressed in a wide variety of tissues. In MC9 mast cell transformants, APS was tyrosine phosphorylated in response to SCF (data not shown). Thus, APS and SH2-B are potentially involved in tyrosine kinase signaling in addition to immunoreceptor complexes. It is particularly important to examine whether APS or related molecules are expressed in c-kit positive cells including hematopietic stem cells.
In conclusion, we identi®ed a new adaptor family containing APS, SH2-B and Lnk which is involved in immunoreceptor signaling. Although their physiological function remains to be clari®ed, they appear to be a link from immunoreceptor complex to Grb2 and other unidenti®ed signaling pathways.
Materials and methods
Cells
Surface IgM-expressing human B cell lines Daudi and Raji were grown in RPMI 1640 containing 10% fetal calf serum (FCS). HEK293T cells were cultured in DMEM containing 10% FCS. MC9 cells were cultured in RPMI medium containing 10% FCS and 10% WEHI conditioned medium as a source of interleukin 3 (Yoshimura et al., 1990) .
Two hybrid screening and cloning of APS
To identify a clone interacting with c-kit tyrosine kinase domain, a two hybrid screen was performed according to Vojtek et al. (1993) . The murine oncogenic mouse c-kit kinase domain (codon 544 ± 975 containing D816V mutation) (Kitayama et al., 1995) was inserted into the pBTM116 vector as a fusion to LexA DNA-binding domain (pBTM-kit) and introduced into the yeast strain L40. The human EB virus transformed lymphocyte cDNA library in the pACT vector (Harper et al., 1993) was introduced into the L40 transformant bearing pBTM-kit with a LiCl protocol. Ten million transformants were selected in synthetic medium lacking histidine, tryptophane and leucine. The isolated colonies were subsequently assayed for b-galactosidase activity on ®lters. The positive library plasmid DNA was isolated by transformation into HB101 and sequenced as described (Hollenberg et al., 1995) . Using oncogenic c-kit kinase domain as bait, we cloned several known and unknown SH2 proteins, which will be described elsewhere. One clone (about 0.8 kb) encoding novel SH2 protein (termed APS) was further characterized. A panel of overlapping longer cDNA clone was obtained by rescreening of a human B cell cDNA library (Clontech), and the longest clone of 2.0 kb was completely sequenced. To obtain the 5'-end, rapid ampli®cation of cDNA ends (RACE) ± PCR (Frohman, 1993) was performed using poly(A) + RNA from human placenta as a mRNA source using the 5'-RACE kit from Gibco-BRL. The major PCR product had a 5' sequence that extended for about 200 bp. After combining all of the sequence information, we obtained a single open reading frame encoding 632 amino acids (Figure 2a) .
Nucleotide accession number
The nucleotide sequence reported in this paper will appear in the GSDB, DDBJ, EMBL and NCBI nucleotide sequence databases with the accession number AB000520.
Construction of fusion proteins
To create Myc-tagged APS (Myc-APS) (codon 2 ± 632) or APS SH2 domain and C-terminal region (Myc-SH2C) (codon 7632) or SH2 domain (Myc-SH2) (codon 404 ± 517), corresponding PCR fragments were subcloned into pCS-MT + (Turner and Weintraub, 1994) in frame. Resulting fusion proteins contained Myc-tag (MEQKLI-SEEDLNE, ®ve times repeated) at the N-terminus. The fusion gene was transferred to a pcDNA3 expression vector using HindIII/XbaI sites. GST fusion proteins of the APS SH2 domain (GST-SH2) (codon 397 ± 551), APS PH domain (GST-PH) (codon 202 ± 312), or C-terminal region (GST-C) (codon 551 ± 632) were created by cloning of PCR fragments containing additional EcoRI and SalI sites into the pGEX-4T-1 vector (Pharmacia). Plasmids were transformed into E coli strain NM522, or TKB1 (Stratagene) for GST-C to phosphorylate C-terminal tyrosine residue, and GST fusion proteins were puri®ed with GSH-Sepharose (Pharmacia). TKB strain carries an active tyrosine kinase domain and tyrosine phosphorylation of GST-C was achieved according to manufacturer's instructions. GST-C produced in NM522 was used to prepare rabbit anti-APS antiserum.
Expression and tyrosine phosphorylation of APS in 293T cells
For in vivo phosphorylation assay in 293T cells, wild type mouse c-kit cDNA in an expression vector pEF-BOS (10 mg) and Myc-APS constructs in pcDNA3 (10 mg) were transfected into cells grown in 10 cm plastic dishes using the calcium phosphate method. After 2 days of transfection, cells were cultured in DMEM containing 0.1% FCS for 16 h, then stimulated with 100 ng/ml stem cell factor (SCF) in the presence of 0.1 mM sodium vanadate for 10 min at 378C. Cells were then solubilized with 1 ml of lysis buer (1.0% Triton X-100 in PBS containing 50 mM NaF, 10 mM sodium pyrophosphate and 1 mM sodium vanadate, 1 mM PMSF). After centrifugation, cleared lysates were incubated with 10 ml of anti-APS antiserum or 1 ml ascites¯uid of anti-Myc monoclonal antibody (9E10) for 1 h at 48C. The immune complexes adsorbed with protein A-Sepharose were resolved on SDS ± PAGE, then immunoblotted with anti-phosphotyrosine (4G10) or anti-Myc monoclonal antibodies as described previously (Yoshimura et al., 1995) .
Analysis of APS in B cells
Raji cells (1610 8 /sample) were cultured in serum-free DMEM medium for 2 h at 378C, then resuspended in 2 ml serum-free DMEM and stimulated with 10 ml of rabbit anti-human IgM (MBL, Japan) in the presence of 0.1 mM vanadate at 378C for indicated periods. After being washed with cold PBS, cells were then solubilized with 1 ml of lysis buer. Cell lysates were incubated with 10 ml of anti-APS antiserum, anti-Cbl (Santa Cruz, sc-170), antiGrb2 (Santa Cruz, sc-255), anti-PI3 kinase p85 subunit (Santa Cruz, sc-423), anti-Shc (Transduction laboratories, S14630), anti-Fyn (Wako chemicals, Japan) or anti-Syk (Wako Chemicals). The immune complexes were analysed by immunoblotting with anti-phosphotyrosine (PY) or indicated antibodies (Yoshimura et al., 1995) . For in vitro binding studies, stimulated or unstimulated Raji cell extracts were incubated with 3 mg of immobilized GST or GST fusion proteins at 48C for 1 h. The protein complexes were washed with the lysis buer and immunoblotted with indicated antibodies.
